Siplizumab
Product Specifications
CAS Number
288392-69-8
Target
Immunology/Inflammation related|||Others
Related Pathways
Immunology/Inflammation|||Others
Purity
1
Bioactivity
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody that targets CD2, selectively depleting effector memory T cells and promoting the relative expansion of alloreactive regulatory T cells in vitro. Siplizumab can be used to treat plaque psoriasis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
034247-ML490 100 µL
CRTC2, NT (CRTC2, TORC2, CREB-regulated transcription coactivator 2, Transducer of regulated cAMP response element-binding protein 2) (MaxLight 490) discontinued
Ask
View Details 
TL314769V 500 µL Each
Annexin V (ANXA5) Human shRNA Lentiviral Particle (Locus ID 308)
Ask
View Details 
